{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:07:37Z","timestamp":1779199657461,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-level Talents Research Start-up Project of Fujian Medical University","award":["XRCZX2020037"],"award-info":[{"award-number":["XRCZX2020037"]}]},{"name":"High-level Talents Research Start-up Project of Fujian Medical University","award":["XRCZX2022001"],"award-info":[{"award-number":["XRCZX2022001"]}]},{"name":"High-level Talents Research Start-up Project of Fujian Medical University","award":["XRCZX2023005"],"award-info":[{"award-number":["XRCZX2023005"]}]},{"name":"High-level Talents Research Start-up Project of Fujian Medical University","award":["XRCZX2023030"],"award-info":[{"award-number":["XRCZX2023030"]}]},{"name":"General Program of the Natural Science Foundation of Fujian Province","award":["2022J01711"],"award-info":[{"award-number":["2022J01711"]}]},{"name":"Government of Fuqing city","award":["2019B003"],"award-info":[{"award-number":["2019B003"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2024YFC3405800"],"award-info":[{"award-number":["2024YFC3405800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02736-x","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:21:11Z","timestamp":1761045671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The nomenclature of fatty liver disease and its impact on obesity traits, insulin resistance, and hepatic fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Liangguang","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruimei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"7","key":"2736_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851\u201364.","journal-title":"Gastroenterology"},{"issue":"8","key":"2736_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"issue":"4","key":"2736_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2736_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","volume":"77","author":"K Staufer","year":"2022","unstructured":"Staufer K, Huber-Schonauer U, Strebinger G, Pimingstorfer P, Suesse S, Scherzer TM, et al. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease. J Hepatol. 2022;77(4):918\u201330.","journal-title":"J Hepatol"},{"issue":"12","key":"2736_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","volume":"20","author":"LA Diaz","year":"2023","unstructured":"Diaz LA, Arab JP, Louvet A, Bataller R, Arrese M. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2023;20(12):764\u201383.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2736_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00448","volume":"7","author":"F Idalsoaga","year":"2020","unstructured":"Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Front Med. 2020;7:448.","journal-title":"Front Med"},{"issue":"7","key":"2736_CR7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, International Consensus P. MAFLD: A Consensus-Driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u20132014. e1.","journal-title":"Gastroenterology"},{"issue":"3","key":"2736_CR8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.31420","volume":"73","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology. 2021;73(3):1194\u20138.","journal-title":"Hepatology"},{"issue":"3","key":"2736_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/hep.32642","volume":"77","author":"LA van Kleef","year":"2023","unstructured":"van Kleef LA, de Knegt RJ, Brouwer WP. Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality. Hepatology. 2023;77(3):942\u20138.","journal-title":"Hepatology"},{"issue":"6","key":"2736_CR10","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"3","key":"2736_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13679-019-00349-x","volume":"8","author":"U Agbim","year":"2019","unstructured":"Agbim U, Carr RM, Pickett-Blakely O, Dagogo-Jack S. Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity. Curr Obes Rep. 2019;8(3):243\u201354.","journal-title":"Curr Obes Rep"},{"issue":"10","key":"2736_CR12","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1194\/jlr.M400159-JLR200","volume":"45","author":"VH Goh","year":"2004","unstructured":"Goh VH, Tain CF, Tong TY, Mok HP, Wong MT. Are BMI and other anthropometric measures appropriate as indices for obesity? A study in an Asian population. J Lipid Res. 2004;45(10):1892\u20138.","journal-title":"J Lipid Res"},{"issue":"4","key":"2736_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.7326\/M19-0477","volume":"172","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang M, Zhao Z, Huang Z, Deng Q, Li Y, et al. Geographic variation in prevalence of adult obesity in China: results from the 2013\u20132014 national chronic disease and risk factor surveillance. Ann Intern Med. 2020;172(4):291\u20133.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2736_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2736_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2736_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.30418","volume":"70","author":"EM Brunt","year":"2019","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Sanyal AJ, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis clinical research N. improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the nonalcoholic steatohepatitis clinical research network treatment trials. Hepatology. 2019;70(2):522\u201331.","journal-title":"Hepatology"},{"issue":"2","key":"2736_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41(2):261\u201370.","journal-title":"Liver Int"},{"issue":"5","key":"2736_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE Mozes","year":"2022","unstructured":"Mozes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022;71(5):1006\u201319.","journal-title":"Gut"},{"key":"2736_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/CLEP.S400150","volume":"15","author":"W Huang","year":"2023","unstructured":"Huang W, Feng R, Xu X, Ma M, Chen J, Wang J, et al. Loss of Anthropometry-Lipids relationship in obese adults: A Cross-Sectional study in Southern China. Clin Epidemiol. 2023;15:191\u2013201.","journal-title":"Clin Epidemiol"},{"key":"2736_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.01.026","author":"ND Shah","year":"2019","unstructured":"Shah ND, Ventura-Cots M, Abraldes JG, Alboraie M, Alfadhli A, Argemi J, et al. Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide. Clin Gastroenterol Hepatol. 2019. https:\/\/doi.org\/10.1016\/j.cgh.2019.01.026.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2736_CR21","doi-asserted-by":"publisher","first-page":"1047794","DOI":"10.3389\/fpubh.2022.1047794","volume":"10","author":"W Su","year":"2022","unstructured":"Su W, Chen M, Xiao L, Du S, Xue L, Feng R, et al. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease. Front Public Health. 2022;10:1047794.","journal-title":"Front Public Health"},{"key":"2736_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1133515","volume":"14","author":"TB Basnet","year":"2023","unstructured":"Basnet TB, Du S, Feng R, Gao J, Gong J, Ye W. Fatty liver mediates the association of hyperuricemia with prediabetes and diabetes: a weighting-based mediation analysis. Front Endocrinol (Lausanne). 2023;14:1133515.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2736_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12944-023-01947-4","volume":"22","author":"Q Liu","year":"2023","unstructured":"Liu Q, Han M, Li M, Huang X, Feng R, Li W, et al. Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study. Lipids Health Dis. 2023;22(1):185.","journal-title":"Lipids Health Dis"},{"issue":"Suppl 1","key":"2736_CR24","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice C","year":"2022","unstructured":"American Diabetes Association Professional Practice C. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17\u201338.","journal-title":"Diabetes Care"},{"key":"2736_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100457","volume":"21","author":"JA Bell","year":"2022","unstructured":"Bell JA, Richardson TG, Wang Q, Sanderson E, Palmer T, Walker V, et al. Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK biobank: a multivariable Mendelian randomization study. The Lancet Regional Health. 2022;21:100457.","journal-title":"The Lancet Regional Health"},{"issue":"3","key":"2736_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275\u201386.","journal-title":"Obes Rev"},{"issue":"1","key":"2736_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2337\/diacare.29.01.06.dc05-1805","volume":"29","author":"HS Kahn","year":"2006","unstructured":"Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29(1):151\u20133.","journal-title":"Diabetes Care"},{"issue":"4","key":"2736_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920\u20132.","journal-title":"Diabetes Care"},{"issue":"1","key":"2736_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-020-01095-4","volume":"19","author":"H Wan","year":"2020","unstructured":"Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2736_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12933-024-02158-6","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, He H, Xie Y, Li J, Luo F, Sun Z, et al. Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study. Cardiovasc Diabetol. 2024;23(1):87.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2736_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"3","key":"2736_CR32","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.","journal-title":"PLoS ONE"},{"key":"2736_CR33","doi-asserted-by":"publisher","first-page":"1086771","DOI":"10.3389\/fpubh.2023.1086771","volume":"11","author":"NS Al Akl","year":"2023","unstructured":"Al Akl NS, Haoudi EN, Bensmail H, Arredouani A. The triglyceride glucose-waist-to-height ratio outperforms obesity and other triglyceride-related parameters in detecting prediabetes in normal-weight Qatari adults: a cross-sectional study. Front Public Health. 2023;11:1086771.","journal-title":"Front Public Health"},{"issue":"1","key":"2736_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2736_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846\u201354.","journal-title":"Hepatology"},{"key":"2736_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2736_CR37","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jhep.2020.08.028","volume":"73","author":"V Ratziu","year":"2020","unstructured":"Ratziu V, Rinella M, Beuers U, Loomba R, Anstee QM, Harrison S, et al. The times they are a-changin\u2019 (for NAFLD as well). J Hepatol. 2020;73(6):1307\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/liv.15139","volume":"42","author":"I Ayada","year":"2022","unstructured":"Ayada I, van Kleef LA, Alferink LJM, Li P, de Knegt RJ, Pan Q. Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups. Liver Int. 2022;42(2):277\u201387.","journal-title":"Liver Int"},{"issue":"5","key":"2736_CR39","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/hep.32499","volume":"76","author":"ZM Younossi","year":"2022","unstructured":"Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022;76(5):1423\u201337.","journal-title":"Hepatology"},{"issue":"1","key":"2736_CR40","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"1","key":"2736_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12876-021-01893-4","volume":"21","author":"Y Yoshimura","year":"2021","unstructured":"Yoshimura Y, Hamaguchi M, Hashimoto Y, Okamura T, Nakanishi N, Obora A, et al. Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study. BMC Gastroenterol. 2021;21(1):321.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"2736_CR42","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/hep.29631","volume":"67","author":"F \u00c5berg","year":"2018","unstructured":"\u00c5berg F, Helenius-Hietala J, Puukka P, F\u00e4rkkil\u00e4 M, Jula A. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population. Hepatology. 2018;67(6):2141\u20139.","journal-title":"Hepatology"},{"issue":"6","key":"2736_CR43","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","volume":"81","author":"D Marti-Aguado","year":"2024","unstructured":"Marti-Aguado D, Calleja JL, Vilar-Gomez E, Iruzubieta P, Rodr\u00edguez-Duque JC, Del Barrio M, et al. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease. J Hepatol. 2024;81(6):930\u201340.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR44","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song SJ, Lai JC, Wong GL, Wong VW, Yip TC. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80(2):e54\u20136.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR45","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","volume":"80","author":"H Hagstrom","year":"2024","unstructured":"Hagstrom H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol. 2024;80(2):e76-7.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR46","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jhep.2023.10.032","volume":"80","author":"U Arora","year":"2024","unstructured":"Arora U, Biswas S, Aggarwal S, Duseja A, Shalimar. MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature. J Hepatol. 2024;80(2):e89\u201391.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR47","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jhep.2023.07.017","volume":"80","author":"V Ratziu","year":"2024","unstructured":"Ratziu V, Boursier J, Fibrosis AGSL. Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD. J Hepatol. 2024;80(2):e51\u20132.","journal-title":"J Hepatol"},{"issue":"5","key":"2736_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J Hepatol. 2024;80(5):694\u2013701.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR49","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.jhep.2023.09.030","volume":"80","author":"T Yang","year":"2024","unstructured":"Yang T, Yin J, Li J, Wang Q. The influence of different combinations of cardiometabolic risk factors on the prevalence of MASLD and risk of advanced fibrosis deserves attention. J Hepatol. 2024;80(2):e82\u20135.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR50","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1016\/j.jhep.2023.08.025","volume":"80","author":"H Perazzo","year":"2024","unstructured":"Perazzo H, Pacheco AG, Griep RH. Collaborators. Changing from NAFLD through MAFLD to MASLD: similar prevalence and risk factors in a large Brazilian cohort. J Hepatol. 2024;80(2):e72\u20134.","journal-title":"J Hepatol"},{"issue":"4","key":"2736_CR51","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1016\/j.jhep.2023.09.033","volume":"80","author":"A Yang","year":"2024","unstructured":"Yang A, Zhu X, Zhang L, Ding Y. Transitioning from NAFLD to MAFLD and MASLD: consistent prevalence and risk factors in a Chinese cohort. J Hepatol. 2024;80(4):e154-5.","journal-title":"J Hepatol"},{"issue":"2","key":"2736_CR52","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3945\/ajcn.2008.26847","volume":"89","author":"KM Flegal","year":"2009","unstructured":"Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009;89(2):500\u20138.","journal-title":"Am J Clin Nutr"},{"key":"2736_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnut.2018.00001","volume":"5","author":"SA Segovia","year":"2018","unstructured":"Segovia SA, Vickers MH, Harrison CJ, Patel R, Gray C, Reynolds CM. Maternal High-Fat and High-Salt diets have differential programming effects on metabolism in adult male rat offspring. Front Nutr. 2018;5:1.","journal-title":"Front Nutr"},{"key":"2736_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050733","author":"F Baldini","year":"2022","unstructured":"Baldini F, Khalil M, Bartolozzi A, Vassalli M, Di Ciaula A, Portincasa P, et al. Relationship between liver stiffness and steatosis in obesity conditions: in vivo and in vitro studies. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12050733.","journal-title":"Biomolecules"},{"issue":"2","key":"2736_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4093\/dmj.2020.0287","volume":"46","author":"H Gao","year":"2022","unstructured":"Gao H, Yang J, Pan W, Yang M. Iron overload and the risk of diabetes in the general population: results of the Chinese health and nutrition survey cohort study. Diabetes Metab J. 2022;46(2):307\u201318.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"2736_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CM9.0000000000001263","volume":"134","author":"YX Xian","year":"2020","unstructured":"Xian YX, Weng JP, Xu F. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chin Med J (Engl). 2020;134(1):8\u201319.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"2736_CR57","doi-asserted-by":"publisher","first-page":"e0263768","DOI":"10.1371\/journal.pone.0263768","volume":"17","author":"M Asadullah","year":"2022","unstructured":"Asadullah M, Shivashankar R, Shalimar, Kandasamy D, Kondal D, Rautela G, et al. Rural-urban differentials in prevalence, spectrum and determinants of non-alcoholic fatty liver disease in North Indian population. PLoS ONE. 2022;17(2):e0263768.","journal-title":"PLoS ONE"},{"key":"2736_CR58","doi-asserted-by":"publisher","first-page":"707402","DOI":"10.3389\/fcimb.2021.707402","volume":"11","author":"Y Du","year":"2021","unstructured":"Du Y, Ding L, Na L, Sun T, Sun X, Wang L, et al. Prevalence of chronic diseases and alterations of gut microbiome in people of Ningxia China during urbanization: an epidemiological survey. Front Cell Infect Microbiol. 2021;11:707402.","journal-title":"Front Cell Infect Microbiol"},{"key":"2736_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2025.05.740","author":"J Huynh","year":"2025","unstructured":"Huynh J, Hoque AR, Reddy SSK. Diagnosis frequency and associated factors of nonalcoholic fatty liver disease among United States hospitalized adults in urban vs rural populations from 2007 to 2019: an emerging public health crisis. Endocr Pract. 2025. https:\/\/doi.org\/10.1016\/j.eprac.2025.05.740.","journal-title":"Endocr Pract"},{"issue":"1","key":"2736_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jesf.2020.07.004","volume":"19","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chen Y, Geng B, Zhang Y, Qin R, Cai Y, et al. Physical activity and liver health among urban and rural Chinese adults: results from two independent surveys. J Exerc Sci Fit. 2021;19(1):8\u201312.","journal-title":"J Exerc Sci Fit"},{"key":"2736_CR61","doi-asserted-by":"publisher","first-page":"1605031","DOI":"10.3389\/ijph.2023.1605031","volume":"68","author":"W Chen","year":"2023","unstructured":"Chen W, Cao L, Wu Z. Association between physical activity and prevalence\/mortality of non-alcoholic fatty liver disease in different socioeconomic settings. Int J Public Health. 2023;68:1605031.","journal-title":"Int J Public Health"},{"key":"2736_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/life12060839","author":"T Pixner","year":"2022","unstructured":"Pixner T, Stummer N, Schneider AM, Lukas A, Gramlinger K, Julian V, et al. The role of macronutrients in the pathogenesis, prevention and treatment of Non-Alcoholic fatty liver disease (NAFLD) in the paediatric population-a review. Life. 2022. https:\/\/doi.org\/10.3390\/life12060839.","journal-title":"Life"},{"key":"2736_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112334","volume":"184","author":"M Georgieva","year":"2023","unstructured":"Georgieva M, Xenodochidis C, Krasteva N. Old age as a risk factor for liver diseases: modern therapeutic approaches. Exp Gerontol. 2023;184:112334.","journal-title":"Exp Gerontol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02736-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02736-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02736-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T10:03:17Z","timestamp":1764756197000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02736-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02736-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Ruimei Feng's correct affiliation is 4 and Dr. Weimin Ye's affiliations are 2,3 and 5.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Review Committee of Fujian Medical University approved the study protocol (approval number, [2017-07] and [2020-58]). All participants provided written informed consent prior to data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}